SPARC and diabetes mellitus: The established diabetic canines (designated as DM) were randomly allocated into three groups (n = 3) and received intravenous injections of either 3 ml of saline, 1 × 107 control MSCs or SPARC-MSCs suspended in 3 ml of saline, administered once weekly for four consecutive weeks.